Purple Biotech (PPBT) Institutional Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free PPBT Stock Alerts $0.49 -0.02 (-4.46%) (As of 11:20 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.83MNumber ofInstitutional Sellers(last 12 months)0 Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024 Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023 Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022 ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% 3/26/2021Susquehanna International Group LLP20,679$79K0.0%N/A0.132% 2/24/2021Virtu Financial LLC22,988$88K0.0%N/A0.146% 2/16/2021Orbimed Advisors LLC346,197$1.32M0.0%N/A2.202% 2/10/2021Renaissance Technologies LLC128,900$491K0.0%N/A0.820% 2/8/2021Washington Trust Bank16,454$63K0.0%N/A0.105% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($1.47M), WuXi AppTec Co. Ltd. ($151K), and Kingswood Wealth Advisors LLC ($137K), Fisher Asset Management LLC ($44K).Learn more on PPBT's institutional investors. What percentage of Purple Biotech stock is owned by institutional investors? 9.64% of Purple Biotech stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech stock? The following institutional investors have purchased Purple Biotech stock in the last 24 months: Armistice Capital LLC ($1.88M), WuXi AppTec Co. Ltd. ($194.14K), Kingswood Wealth Advisors LLC ($172.40K), and Fisher Asset Management LLC ($32.20K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 2,280,912 shares in the last 24 months. This purchase volume represents approximately $1.88M in transactions. Related Companies: RedHill Biopharma Institutional Ownership AgeX Therapeutics Institutional Ownership MIRA Pharmaceuticals Institutional Ownership Tonix Pharmaceuticals Institutional Ownership Avalo Therapeutics Institutional Ownership Monopar Therapeutics Institutional Ownership Eterna Therapeutics Institutional Ownership Galera Therapeutics Institutional Ownership Edesa Biotech Institutional Ownership Moleculin Biotech Institutional Ownership This page (NASDAQ:PPBT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.